Main Navigation

Dr. Truman Milling, LSS PI, publishes research on use of FXa inhibitors

AUSTIN – May 10, 2017 – Dr. Truman Milling of our Seton Healthcare hub in Austin recently published an article on the unmet need for a reversal agent for the management of FXa inhibitor-associated bleeding. The study, with co-author Dr. Jennifer Frontera, was published in the American Journal of Managed Care.

Exploring Indications for the Use of Direct Oral Anticoagulants and the Associated Risks of Major Bleeding